News & Views
EU Project Identifies Potential New Treatments for Cancer
Jan 20 2020 Read 433 Times
Research undertaken as part of the European Lead Factory Project, brought together scientists from the German Cancer Research Center (DKFZ), the Pivot Park Screening Centre and BioAscent in the discovery of potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases.
The collaborative group proposed a study of Kallikrein-related peptidase 6 (KLK6) in the development, invasiveness and metastasis of some cancers, including colon cancer and melanomas.
Initial high throughput screening performed at the Pivot Park Screening Centre identified a cluster of initial hits that showed consistent inhibitory activity against KLK6; these were improved on using multi-step synthesis procedures to produce novel chiral compounds that were tested using a range of biophysical and biochemical assays. The team of biologists and chemist scientists has since transitioned to BioAscent.
Dr Phil Jones, Chief Scientific Officer at BioAscent, said: “Historically the infrastructure and expertise to carry out this type of approach has only really been available in major pharma companies. BioAscent now has the facilities and breadth of expertise and experience to perform these studies and provide our clients with excellent opportunities to advance their drug discovery projects.”
Dr Aubry Miller, Cancer Drug Discovery/Wirkstoffforschung Group Leader, DKFZ, was enthusiastic about the collaboration, commenting: “More importantly, the scientists (now at BioAscent) who were involved in the hit development stage, were fully committed to the success of the project, bringing their own ideas and solutions, which made my role as project owner very comfortable. I would be very happy to work with them again.”
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Chromatography - The Purification of Crown Ether Samples by a Quaternary Solvent Flash Chromatography System - New Wettable Phase Thrives in Water - Reduced Surface Activity...
View all digital editions
Mar 01 2020 Chicago, IK, USA
Mar 04 2020 Beijing, China
Mar 05 2020 New Delhi, India
Mar 11 2020 Guangzhou, China
Mar 16 2020 Tokyo, Japan